Company: AGGI
Filing Date: 2025-10-31
Form Type: 10-12G
Source: 0001683168-25-007875
Chunk: 51

Company: Allied Energy, Inc.
Filing Date: 2025-10-31
Form: 10-12G
Chunk 51
---
 | at least one year has elapsed from the time that the issuer filed current comprehensive disclosure with the SEC reflecting its status as an entity that is not a shell company.                                                                                                        |

Neither
the Company nor its officer and director has any present plan, proposal, arrangement, understanding or intention of selling any unissued
or outstanding shares of common stock in the public market subsequent to a business combination. Nevertheless, in the event that a substantial
number of shares of our common stock were to be sold in any public market that may develop for our securities subsequent to a business
combination, such sales may adversely affect the price for the sale of the Company’s common stock securities in any such trading
market. We cannot predict what effect, if any, market sales of currently restricted shares of common stock or the availability of such
shares for sale will have on the market prices prevailing from time to time, if any.

(b) Holders.

As of October
30, 2025, the Company had 513 shareholders of record.

| 32 |

(c) Dividends.

The Company
has not paid any cash dividends to date and does not anticipate or contemplate paying dividends in the foreseeable future. It is the
present intention of management to utilize all available funds for the development of the Company’s business.

(d) Securities Authorized for Issuance under Equity Compensation Plans.

None.

ITEM 10. RECENT SALES OF UNREGISTERED SECURITIES.

Set forth
below is information regarding all securities sold or issued by the Company within the past three years that were not registered under
the Securities Act of 1933, as amended (the “Securities Act”). Except as stated below, no underwriters were involved in the
transactions, and no underwriting discounts or commissions were paid. The issuances described below were exempt from registration under
the Securities Act pursuant to Section 4(a)(2) thereof as transactions not involving a public offering. The securities were issued to
a limited number of persons who were either accredited investors, officers, directors, or related parties with knowledge of the Company’s
business, and no general solicitation or advertising was used in connection with the issuances.

On October
16, 2024, the Company entered into an Equity Exchange Agreement with Metamexx Corp (“Metamexx”), a wholly owned subsidiary
of the Company, BILI, and the shareholders of BILI (the “Exchange Agreement”). Pursuant to the Exchange Agreement, the Company,
through Metamexx, acquired